Author | Alex Delaney-Gesing


ASRS 2020: How one surgeon is integrating recent retina advances in COVID-19

August 02, 2020


S.K. Steven Houston III, MD, discusses retina innovations in use in his practice, including the NGENUITY 1.4 upgrade from Alcon, and adapting to ever-changing operating room spacing and set-up in the COVID-19 environment

ASRS 2020: Diabetic retinopathy progression in anti-VEGF versus FA implant

August 01, 2020


Caesar Luo, MD, shares the take-away points from his ASRS presentation, and how the topics from his talk may be applied day to day in retinal practice.

ASRS 2020: AsclepiX lead candidate holds potential for wet AMD, DME, RVO

July 31, 2020


Theresa Heah, MD, provides an update on AsclepiX’s AXT107, which is derived from a cryptic peptide within collagen IV that works by activating naturally existing, homeostatic mechanisms of angiogenesis.

ASRS 2020: What Aviceda’s lead candidate AVD-104 may mean for dry AMD

July 30, 2020


Derek Kunimoto, MD, JD, focuses on Aviceda's technology, which will aim to target various immune system responses that contribute to pathology associated with dry AMD.